170800 ⎘
Detection or diagnosis of diseases; Endocrine or metabolic disorders Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Adiponectin expression-inducing agents and uses thereof
#302Assay for phospholipidosis
#303Method of diagnosis of obesity
#304Prediction method for lipidosis
#305HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR
#306Methods for inhibiting adipogenesis and for treating type 2 diabetes
#307Pharmaceutical compositions and methods for metabolic modulation
#308Method, reagent and kit for determination of cholesterol in very low-density lipoprotein remnant (vldl remnant)
#309Methods and compounds for modulating triglyceride and vldl secretion
#310Multidimensional mass spectrometry or serum and celluar lipids directly from biologic extracts
#311Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
#312Novel antibacterial agents
#313Methods for identifying agents that modulate GPR105 activity
#314Dietary calcium for reducing the production of reactive oxygen species
#315Methods of reducing the production of reactive oxygen species and methods of screening or identifying compounds and compositions that reduce the production of reactive oxygen species
#316Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same
#317Modulation of s6 kinase activity for the treatment of obesity
#318Mammalian obestatin receptors
#319Computer systems and methods for inferring casuality from cellular constituent abundance data
#320Method for examining obesity or leanness
#321GLUCOSE TRANSPORT-RELATED GENES, POLYPEPTIDES, AND METHODS OF USE THEREOF
#322Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
#323Treatment and Diagnosis of Insulin-Resistant States
#324Methods of inhibiting a GPCR
#325Method of diagnosis of obesity
#326Phospholipid transfer protein (PLTP) and cholesterol metabolism
#327Methods of treatment of feeding disorders or disorders of glucose uptake and for modifying metabolism and identifying therapeutic reagents therefor
#328Computer systems and methods for inferring causality from cellullar constituent abundance data
#329Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof
#330Fluoresence assay for mtp activity
#331Detection of cholesterol ozonation products
#332Methods of assessing endothelial dysfunction using acute transient responses following fat administration
#333Method of evaluating compound efficacious in treating obesity by using slc25a10
#334Method for measuring oxidized LDL-CRP complex and measurement kit
#335Prevention and treatment of atherosclerosis by reducing carbamylation of LDL or the effects of carbamylated LDL
#336Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
#337Glucose-transport related genes, polypeptides, and methods of use thereof
#338Method of quantifying small-sized low density lipoprotein
#339Oxidised fragments of apolioprotein B and their uses
#340Use of resveratrol to regulate expression of apolipoprotein A1
#341Proteins involved in the regulation of energy homeostasis
#342Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
#343Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions
#344Receptor and screening methods
#345Metabolism-modulating agents and uses therefor
#346Method for detecting intracellular cholesterol
#347Methods for the treatment or prevention of obesity
#348Metabolite markers for weight management
#349Multiple quantification method for cholesterol in low-density lipoproteins
#350Use of sglt homolog
#351Non-precipitating bodily fluid analysis system
#352Bodily fluid analysis system
#353Stable lipid standards
#354Methods for detection of the Ob receptor and the diagnosis of body weight disorders, including obesity and cachexia
#355Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#356Method for analyzing blood for cholesterol components
#357Method of measuring lipid in specific lipoprotein
#358Test device for determining the concentration of LDL-cholesterol in a sample
#359Assay and method for quantifying the levels of steryl esters and free sterols in starch-containing food products
#360Functional assay of high-density lipoprotein
#361RIP140 regulation of glucose transport
#362Method of selectively measuring triglycerides
#363Animal model for raising HDL-cholesterol with niacin
#364MEASUREMENT OF MELANOCORTIN PEPTIDES AND USES THEREOF
#365Molecular modification assays involving lipids
#366Assay device for direct measurement of LDL cholesterol
#367Inhibitors of inflammatory gene activity and cholesterol biosynthesis
#368Sequential ordered fatty acid alpha oxidation and delta9 desaturation are major determinants of lipid storage and utilization in adipocytes
#369High-density lipoprotein assay device and method
#370Methods and compositions to lower plasma cholesterol levels
#371Treatment of cancer by administration of perfluorooctanoic acid
#372Direct measurement of chlolesterol from low density lipoprotein with test strip
#373Treatment and diagnosis of insulin-resistant states
#374Methods and compositions for preventing obesity and obesity related disorders
#375Method of lipid assay and reagent for use therein
#376SIRT1 modulation of adipogenesis and adipose function
#377Adipocytes and uses thereof
#378Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car
#379Detection of cholesterol ozonation products
#380Fluorescence assay for measuring the rate of cholesterol ester transfer
#381Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
#382Compositions and methods for modulating serum cholesterol
#383Agonists and antagonists of prolixin for the treatment of metabolic disorders
#384Methods and compositions comprising FATP5 for use in the diagnosis and treatment of metabolic disorders
#385Method for selecting an optimal diet and exercise regimen based on LDL and HDL subclass determination
#386Method of pretreatment of sample for quantitating cholesterol and method for quantitating cholesterol in specific lipoproteins by using the same
#387Methods of using quantitative lipid metabolome data
#388Test strip for determining concentration of multiple analytes in a single fluid sample
#389Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels
#390Predicting sphingolipidoses (fabry's disease) and decision support
#391Use of remnant lipoprotein in the treatment and prevention of cardiovascular disease